MED12 mutations in the N-terminus were linked to NOTCH signaling activation in chronic lymphocytic leukemia, whilst the activation of NOTCH signaling is a promotor of disease progression and forms a supportive microenvironment in MM [48,49], therefore likely to play a role in its pathogenesis. This evidence concerns the gene MED12 and Miyoshi myopathy.